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Alginate and chitosan nanoparticles were synthesized by ionic gelation of the polymers in the presence of stabilizers 
(PEG 1500, PEG 6000, TWEEN 80). The stability of 210-240 nm Ca-alginate colloids is affected by nanoparticles 
ageing and by the presence of a stabilizer. The diameter of chitosan nanoparticles is in the range of 180 to 260 nm 
and depends on polymer concentration in the reaction mixture, its molecular weight, and stabilizer type. The 
nanoparticles efficiently entrap a model protein, bovine serum albumin, in the amount up to 0.24 mg per 1 mg of 
polysaccharide.  
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1. Introduction 
Development of new nanosized vehicles that successfully entrap biologically active substances is one 
of the main directions in biomaterials science. Encasing in a polymeric matrix enhances chemical stability 
of the substances, improves their solubility in biological liquids, controls release of the active 
components, and alters drugs body distribution [1]. Such nanoparticles create a foundation for targeted 
delivery systems with improved blood circulation time and lower systemic toxicity [1-2]. 
Biocompatible and non-toxic biopolymers (chitosan, alginate, pectin, etc.) are often used as structural 
components for nano- and microcontainers [1-3]. Recently, polysaccharide nanoparticles have been 
reported as carriers for various classes of drugs: anti-inflammatory (ammonium glycyrrhizinate [4], 
prednisolone [5]), anticancer drugs (doxorubicine [6], taxol [7]), antiviral agents (lopinavir [8]), 
antibacterial drugs (rifampicin, isoniazid, pyrazinamide, ethanbutol [9]), proteins [10]. The common 
preparation technique for the nanoparticles is based on emulsification of diluted polysaccharide solutions 
in immiscible organic solvent followed by gelation of the polymer. The particles of 2-10 micron diameter 
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are easily produced by the method [11, 12], the preparation of nanoparticles of smaller diameter was 
rarely reported [9]. 
Here we propose a method that allows to obtain stable colloids of calcium alginate and chitosan gel 
particles with a diameter of 180-250 nm while swollen in water and 50-80 nm size after lyophilisation. 
The benefit of it is that only nontoxic compounds listed in the FDA Inactive Ingredients Database are 
used. It is based on crosslinking of corresponding polysaccharide with multivalent ions in an aqueous 
solution containing polyethylene glycol stabilizers. Incorporation of hydrophilic PEG tails on the surface 
of the nanoparticles allows to achieve high colloidal stability of the aqueous dispersion. A model protein, 
bovine serum albumin, was entrapped in the nanoparticles with high efficiency (ca. 0.24 mg per 1 mg of 
polysaccharide). The mixed protein/polysaccharide nanoparticles with hydrophobic patches of protein in 
the interior are considered perspective vehicles for hydrophobic drugs, such as anticancer drugs. 
2. Materials and methods 
Alginic acid (from brown algae, 240 kDa), chitosan (from crab shell, 800 kDa), polyethylenimine 
(PEI), poly(sodium-4-styrenesulfonate) (PSS), albumin from bovine serum (BSA), fluorescein 
isothiocyanate (FITC), polyethylene glycol (PEG) with molecular weight of 1500 (PEG 1500) were 
obtained from Sigma. TWEEN 80 and PEG with molecular weight of 6000 (PEG 6000) were from 
Panreac Quimica S.A.U.  FITC-labeled albumin (BSA-FITC) was prepared according [13]. 
2.1. Ca-alginate nanoparticles preparation 
A 2 Ɇ solution of calcium chloride (1.5 mL) was added dropwise to 30 mL of a 0.1 wt % sodium 
alginate solution (pH 5.0–5.5) under continuous ultrasonication (35 kHz). TWEEN 80 (0.5-5.0 wt %) or 
PEG 1500 (5-25 wt %) was added to the solution of sodium alginate prior crosslinking with Ca2+ ions. 
The obtained dispersion was ether aged in the supernatant at room temperature for 24 h or, on one 
occasion, separated immediately by centrifugation, rinsed twice with distilled water, and dispersed in a 
small volume of the solvent. 
2.2. Chitosan nanoparticles preparation 
Chitosan (0.025–0.75% w/v) was dissolved in aqueous acetic acid (2 % v/v, pH 3.0). TWEEN 80 (0.5-
5.0 wt %), PEG 1500 (9-30 wt %) or PEG 6000 (9-30 wt %) was added to the solution of chitosan as a 
stabilizer. A sodium sulfate solution (20 wt %) was added dropwise to the chitosan solution under 
simultaneous stirring at 420 rpm and ultrasonication (35 kHz). After adding sodium sulfate the stirring 
and sonication were continued for 1 h. Chitosan nanoparticles were separated from supernatant by 
centrifugation at 4000 rpm and redispersed in water. 
2.3. Preparation of BSA-loaded nanoparticles 
BSA was admixed to a polysaccharide solution (0.25% for chitosan, 0.1 % for alginate) to a final ratio 
varying from 1:10 to 2:1 by weight. The BSA-loaded alginate and chitosan nanoparticles were formed 
using the same procedures as those for unloaded nanoparticles. The concentration of BSA in chitosan 
nanoparticles was determined by the Lowry method [14]. BSA-FITC was used for encapsulation in Ca-
alginate nanoparticles and its concentration was evaluated spectrofluoremetrically (Ȝex = 495 nm, Ȝem = 
520 nm, a Solar CM 2203, Belarus spectrofluorometer). The BSA encapsulation efficiency (EE) of 
nanoparticles was calculated as: EE(%) = (1 – C1/C0)·100, where C0 and C1 are the total and supernatant 
concentrations of BSA. 
 O. Masalova et al. /  Physics Procedia  40 ( 2013 )  69 – 75 71
2.4. Chitosan hydrolysis 
Chitosan (1 g) was dissolved in 100 mL of a 1% lactic acid solution and kept at 20±1 0ɋ. This 
hydrolyzing agent has been chosen due to the fact that no additional deacetylation of chitosan is observed 
under these conditions [15]. Aliquots were withdrawn after certain time periods and their intrinsic 
viscosity was measured until no further decrease was observed. The hydrolyzed for 90 days chitosan was 
precipitated by 0.1 M NaOH (pH 9.0), rinsed with distilled water to pH 7.0, and lyophilized. Molecular 
weights of unhydrolyzed (800 kDa) and hydrolyzed (310 kDa) chitosan were determined by viscosimetry 
in a 0.2 Ɇ sodium acetate–2% acetic acid using the following constants in the Mark-Houwink equation 
(25°C): a = 0.85, Km = 1.38·10-4 [15]. 
2.5. Nanoparticles characterization 
The morphology and size of nanoparticles were studied by atomic force microscopy (Multimoda III, 
Veeco, USA) and transmission electron microscopy (JEM-100 CX, Japan). For TEM, a drop of colloid 
was placed on a copper grid with polyvinyl formal film. The samples for AFM were prepared by 
adsorbing the polysaccharide nanoparticles on a silicon substrate modified with a PEI and PEI/PSS 
sublayer for Ca-alginate and chitosan nanoparticles, accordingly. The mean hydrodynamic diameter of 
swollen polysaccharide nanoparticles was estimated by light scattering [16]. 
3. Results and discussion 
3.1. Calcium alginate nanoparticles 
Calcium cations have been chosen as a gelating agent for alginate because of their biocompatibility, 
non-toxicity, and high gelating ability towards such polysaccharides, as alginates and pectins [3]. Besides, 
they promote formation of smaller particles in comparison with other cations [17]. 
The synthesized calcium alginate nanoparticles are negatively charged and readily adsorb on the 
















a                                                                                b 
Fig. 1. a) AFM image of calcium alginate nanoparticles on a PEI-coated surface; b) apparent diameter of Ca-alginate nanoparticles 
(black – dried, grey – swollen) prepared in the presence of different stabilizers 
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Dried particles are flat and have a round form (fig. 1a). As determined from AFM images analysis, in 
all synthesized samples the mean nanoparticles diameter does not exceed 280 nm, and in some cases, it is 
less than 130 nm. The particles height is below 20 nm. At the same time, the mean hydrodynamic 
diameter of particles in water varies from 210 to 540 nm (fig. 1b). It indicates that initially swollen in 
water gel particles collapse as drying occurs. The size distribution and stability of the Ca-alginate colloids 
are affected by ageing in the supernatant and the presence of the stabilizers. However, the stabilizer type 
and its concentration do not essentially influence the size of lyophilized nanoparticles (fig. 1b, black).  
At the same time, the apparent diameter of swollen prepared nanoparticles obtained with TWEEN 80 
is somewhat smaller than in the presence of PEG. TWEEN 80 is an nonionogenic surfactant with critical 
micelle concentration of 0.01 mM and HLB value of 15 [18]. Being adsorbed on the surface of calcium 
alginate nanoparticles, TWEEN 80 apparently forms a shell that structure reminds that of a micelle. The 
interaction between neighboring hydrophobic tails prevents extreme swelling of nanoparticles in water. 
We assume that the main role of PEG during the synthesis consists in increasing viscosity of the 
reaction mixture, thus decreasing the rate of nanoparticles aggregation. PEG macromolecules apparently 
adsorb on the surface of already formed nanoparticles through hydrogen bounding [19]; their presence 
results in less sticking of nanoparticles in concentrated colloids. Stable for more than 30 days calcium 
alginate colloids of 200-300 nm particles are formed in the presence of 15 wt % PEG 1500 and 0.5 – 5 wt 
% TWEEN 80. However, the utilization of PEG solutions with a concentration higher than 15 wt.% 
results in highly dispersed nanoparticles due to uneven distribution of the crosslinking agent CaCl2 in the 
viscous solution. 
3.2. Chitosan nanoparticles 
Chitosan nanoparticles were obtained by crosslinking polysaccharide macromolecules with sulfate 
anions. A higher than 0.75 % concentrations of the polymer is not practical because viscosity of the 
solution becomes too high. As a consequence, a homogeneous distribution of the added sodium sulfate is 
not possible; it would have led to the formation of agglomerates. The addition of a stabilizer (TWEEN 80, 
PEG 1500, PEG 6000) in a chitosan solution during the synthesis results in a reduction of the 
nanoparticles hydrodynamic diameter by approximately 12-30 % (fig. 2) but the type and concentration of 
the stabilizer insignificantly affect the nanoparticles size.  
 
a                                                                               b 
Fig. 2  (a) Apparent hydrodynamic diameter of chitosan nanoparticles prepared at different concentrations of stabilizers; (b) 
Influence of chitosan concentration on nanoparticle hydrodynamic diameter. Molecular weight of chitosan is 800 kDa 
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However, prepared without stabilizers colloids are collapsed in one day. The utilization of any 
stabilizer on the preparation stage increases later colloidal stability of the nanoparticles in water. No 
separation of colloids prepared in the presence of TWEEN 80 was observed after 30 days. We assume 
that the forces behind the interaction of TWEEN 80 and PEG with of chitosan nanoparticles that support 
the high stability of the colloids are similar to the discussed above for alginate nanoparticles. 
By changing the polymer concentration in the reaction mixture the size of formed gel nanoparticles 
can be slightly altered (fig. 2b). A decrease in chitosan concentration from 0.5 to 0.025 wt.% leads to a 
1.3 fold reduction of the average hydrodynamic diameter of the nanoparticles. The data are in good 
agreement with Ref.20 on the influence of chitosan concentration on the size of nanoparticles prepared by 
sodium tripolyphosphate mediated gelation. 
The chitosan nanoparticles have positively charged surface and form a uniform layer on a negatively 
charged PEI/PSS precursor film (fig. 3a). They are monodisperse and have a spherical shape with the 
diameter of about 80 nm (fig. 3b). The size of these nanoparticles is 2.8 times smaller than that 
determined by light scattering method (~ 220 nm) in water; the difference is caused by gel nanoparticles 
swelling like that for calcium alginate particles. 
The size of particles formed by ionic gelation of a biopolymer strongly depends on its molecular 
weight [21]. Chitosans of two different molecular weights were analyzed in order to develop a reliable 
method of formation of chitosan nanoparticles with a given size. Under similar conditions, 800 kDa 
chitosan produces nanoparticles of a 220 nm diameter, while the hydrodynamic diameter of nanoparticles 
prepared from the sample with Mw 310 kDa was ca.190 nm, and those calculated from TEM data – 80 
and 50 nm, accordingly. This trend of decreasing particle size with reducing chitosan molecular weight 
may be explained by larger initial globule size of higher molecular weight chitosan that result in 
nanoparticles with increasing diameter. The similar results have been previously reported for chitosan-





Fig. 3 AFM (ɚ) and TEM (b) of chitosan (800 kDa) nanoparticles 
 
3.3. Encapsulation  of BSA in alginate and chitosan nanoparticles 
BSA was incorporated into both alginate and chitosan nanoparticles by admixing the protein to a 
polysaccharide solution before the corresponding nanoparticles were formed. The BSA encapsulation 
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efficiency (EE) was significantly affected by its initial concentration in the reaction mixture. For example, 
the encapsulation efficiency by alginate nanoparticles from the reaction mixture with a 0.25 mg/mL BSA 
concentration is more than 99 %. An increase in protein concentration (from 0.25 to 1.0 mg/mL) leads to 
a decrease in encapsulation efficiency to 15 %. 
In the case of chitosan nanoparticles, a fourfold increase of initial protein concentration (from 0.25 to 
1.0 mg/mL) enhances the BSA encapsulation efficiency approximately two times (table 1). However, any 
further increase in protein concentration does not change its amount included per 1 mg of chitosan. The 
maximum capacity of chitosan nanoparticles for the protein of ca. 0.24 mg/mg was observed in the range 
of BSA concentrations from 1.0 to 5.0 mg/mL. The amount is comparable previously reported data on 
BSA entrapment in chitosan nanoparticles [24]. 
 
Table 1. BSA entrapment efficiency in chitosan nanoparticles 
 
Initial BSA concentration, 
mg/ml 
Chitosan:BSA ratio in initial 
solution 
EE, % Amount BSA in the nanoparticles, 
mg per mg of chitosan 
0.25 10:1 25.0±1.0 0.02 
0.5 5:1 45.0±2.0 0.09 
1.0 5:2 53.0±1.0 0.21 
2.5 1:1 24.0±4.0 0.24 
5.0 1:2 13.0±1.0 0.24 
4. Conclusion 
A non-emulsion method of preparation of stable aqueous colloids of alginate and chitosan gel-like 
nanoparticles is developed. By varying synthesis conditions (type of stabilizer and its concentration, 
molecular weight and concentration of biopolymer) calcium alginate nanoparticles with a diameter from 
210 to 240 nm and chitosan nanoparticles with a diameter from 180 to 260 nm in water are obtained. The 
size of lyophilized chitosan nanoparticles does not exceed 80 nm. By admixing protein to polysaccharide 
solution prior the nanoparticles formation, its efficient encapsulation is achieved. The formed 
polysaccharides nanoparticles are promising carriers for biologically active compounds. 
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